VistaGen Therapeutics
VTGN
VTGN
50 hedge funds and large institutions have $30.1M invested in VistaGen Therapeutics in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 4 closing their positions.
Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
17
Reduced
11
Closed
4
Calls
$437K
Puts
$73K
Net Calls
+$364K
Net Calls Change
+$339K
Top Buyers
| 1 |
1
Jane Street
New York
|
$190K |
| 2 |
AI
2
AdvisorShares Investments
Bethesda,
Maryland
|
$406K |
| 3 |
SC
3
Stempoint Capital
New York
|
$4.12M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$69.3K |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$86.7K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CSS
51
Cubist Systematic Strategies
Stamford,
Connecticut
| – | – | -10,088 | Closed |
|
|
BT
52
Banque Transatlantique
Paris,
France
| – | – | -1,000 | Closed |
|
|
SIC
53
SJS Investment Consulting
Sylvania,
Ohio
| – | – | -100 | Closed |
|
54
Barclays
London,
United Kingdom
| $0 | 1 | – | – |
|
55
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|